http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112553296-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fca43599e9fad5642b7132fe14c9262 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-61 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-61 |
filingDate | 2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad48b7888204758b2e5a82b5b08f3f72 |
publicationDate | 2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112553296-A |
titleOfInvention | Experimental research method for auxiliary blood fat reducing effect of euphoria tablet |
abstract | The invention relates to an experimental study method of auxiliary hypolipidemic effect of a euphoria tablet, which comprises an anti-hyperlipidemia experimental study step, an anticoagulation and thrombolysis experimental study step and pharmacokinetic experimental analysis. The purpose of the present invention is to easily determine the pharmacokinetics of a euphoric tablet and predict the therapeutic effect of the euphoric tablet. The invention obtains the good auxiliary hypolipidemic effect of the euphoria tablet through experiments. |
priorityDate | 2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.